Schedule 13G ownership disclosure

PSYENCE BIOMEDICAL LTD

Class A Common Stock · CUSIP: 74449F209

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Harraden Circle Investments, LLC

    Shares: 182,323 · Class: 5.32%

  • Harraden Circle Investors GP, LP

    Shares: 182,323 · Class: 5.32%

  • Harraden Circle Investors GP, LLC

    Shares: 182,323 · Class: 5.32%

  • Harraden Circle Investors, LP

    Shares: 91,162 · Class: 2.66%

  • Harraden Circle Special Opportunities, LP

    Shares: 91,161 · Class: 2.66%

  • Frederick V. Fortmiller, Jr.

    Shares: 182,323 · Class: 5.32%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-020385
Form type
SCHEDULE 13G/A
Filer
Harraden Circle Investments, LLC
CIK
CIK 1910592
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub